Literature DB >> 10910247

Angiogenesis of liver metastases: role of sinusoidal endothelial cells.

P Gervaz1, B Scholl, C Mainguene, S Poitry, M Gillet, S Wexner.   

Abstract

PURPOSE: Tumor-induced angiogenesis requires migration and remodeling of endothelial cells derived from pre-existing blood vessels. Vascular endothelial growth factor is the growth factor most closely implicated in the development of neovessels in colon cancer. However, vascular endothelial growth factor-specific receptors flt-1 and KDR mRNA expression are absent in normal sinusoid vessels surrounding vascular endothelial growth factor-producing secondary hepatic tumors. Thus, the potential role of sinusoidal endothelial cells in the mechanism of neovessel formation within liver metastatic carcinomas remains unclear. The purpose of this study was to determine whether sinusoidal endothelial cells are involved in tumor angiogenesis in a syngeneic model of liver metastases from colorectal cancer.
METHODS: Sinusoidal endothelial cells were identified by fluorescence microscopy after uptake of acetylated low density lipoprotein labeled with a fluorescent probe (dioctadecylindocarbocyanine). One hundred microliters of dioctadecylindocarbocyanine acetylated low density lipoprotein were injected intraportally at the start of experiment in BD IX rats. Two days later, intraportal injection of 10(7) DHD K12, a chemically induced colon carcinoma cell line, was performed in syngeneic BD IX rats. Animals were killed one week later and the livers were processed for routine histologic examination and immunohistochemistry using the rat endothelial cell antigen-1 monoclonal antibody.
RESULTS: In normal parenchyma fluorescence was associated with sinusoidal cells but not with endothelium of large blood vessels. Thus, specific acetylated low density lipoprotein uptake allowed histological differentiation of sinusoidal endothelial cells from other large-vessel endothelial cells present in the hepatic parenchyma. In tumor-bearing liver a spatial gradient of fluorescence was generated. Labeled cells accumulated at the periphery of the metastases. When tumors grow beyond 200 microm, neovessel formation was observed; there was an invasion of fluorescent-labeled cells from the periphery, which were arranged in a tubular formation within neoplasia.
CONCLUSION: In liver metastases tumor vessels are lined with sinusoidal endothelial cells. Identification of a specific cell type involved in the formation of the stromal compartment of tumors has important implications. Sinusoidal endothelial cells express well-characterized surface receptors and differ morphologically and metabolically from large-vessel endothelia. They should be considered as attractive targets for future and existing antiangiogenic strategies directed against the stromal compartment of liver metastases.

Entities:  

Mesh:

Year:  2000        PMID: 10910247     DOI: 10.1007/bf02237364

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  12 in total

1.  Fas/CD95 signaling rather than angiogenesis or proliferative activity is a useful prognostic factor in patients with resected liver metastases from colorectal cancer.

Authors:  Hisashi Onodera; Akira Mori; Satoshi Nagayama; Akihisa Fujimoto; Tsuyoshi Tachibana; Yoshikuni Yonenaga; Tatsuaki Tsuruyama
Journal:  Int J Colorectal Dis       Date:  2005-04-22       Impact factor: 2.571

2.  Omega-3 polyunsaturated fatty acids promote liver regeneration after 90% hepatectomy in rats.

Authors:  Yu-Dong Qiu; Sheng Wang; Yue Yang; Xiao-Peng Yan
Journal:  World J Gastroenterol       Date:  2012-07-07       Impact factor: 5.742

3.  New specific molecular targets for radio-chemotherapy of rectal cancer.

Authors:  Kristin Snipstad; Christopher G Fenton; Jørn Kjaeve; Guanglin Cui; Endre Anderssen; Ruth H Paulssen
Journal:  Mol Oncol       Date:  2009-11-25       Impact factor: 6.603

4.  Predicting survival after pulmonary metastasectomy for colorectal cancer: previous liver metastases matter.

Authors:  Ulrich Landes; John Robert; Thomas Perneger; Gilles Mentha; Vincent Ott; Philippe Morel; Pascal Gervaz
Journal:  BMC Surg       Date:  2010-06-03       Impact factor: 2.102

5.  Expression of angiostatin cDNA in human hepatocellular carcinoma cell line SMMC-7721 and its effect on implanted carcinoma in nude mice.

Authors:  Kai-Shan Tao; Ke-Feng Dou; Xing-An Wu
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

6.  Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor.

Authors:  Michael K Connolly; Jon Mallen-St Clair; Andrea S Bedrosian; Ashim Malhotra; Valery Vera; Junaid Ibrahim; Justin Henning; H Leon Pachter; Dafna Bar-Sagi; Alan B Frey; George Miller
Journal:  J Leukoc Biol       Date:  2009-12-30       Impact factor: 4.962

Review 7.  The immunological and metabolic landscape in primary and metastatic liver cancer.

Authors:  Xin Li; Pierluigi Ramadori; Dominik Pfister; Marco Seehawer; Lars Zender; Mathias Heikenwalder
Journal:  Nat Rev Cancer       Date:  2021-07-29       Impact factor: 60.716

8.  Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancer.

Authors:  Umut Varol; Esin Oktay; Mustafa Yildirim; Zeki Gokhan Surmeli; Ahmet Dirican; Nezih Meydan; Burcak Karaca; Bulent Karabulut; Ruchan Uslu
Journal:  Mol Clin Oncol       Date:  2013-11-12

Review 9.  Vessel co-option in cancer.

Authors:  Elizabeth A Kuczynski; Peter B Vermeulen; Francesco Pezzella; Robert S Kerbel; Andrew R Reynolds
Journal:  Nat Rev Clin Oncol       Date:  2019-08       Impact factor: 66.675

10.  Vitronectin in human hepatic tumours contributes to the recruitment of lymphocytes in an alpha v beta3-independent manner.

Authors:  S Edwards; P F Lalor; C Tuncer; D H Adams
Journal:  Br J Cancer       Date:  2006-11-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.